存心 发表于 2025-3-23 10:33:36
http://reply.papertrans.cn/32/3190/318953/318953_11.pngCLAIM 发表于 2025-3-23 16:48:16
B Lymphocytes in Cancer Immunologyh and impair protective T-cell responses. Therefore, methods to eliminate autoreactive B cells, or switch them to a B effector-1 (Be-1) phenotype that amplifies Th1/Tc1-type T-cell responses, which are typically associated with effective antitumor responses, may improve the clinical outcomes of T-ce辩论 发表于 2025-3-23 20:23:49
http://reply.papertrans.cn/32/3190/318953/318953_13.pngTOXIN 发表于 2025-3-23 22:32:08
http://reply.papertrans.cn/32/3190/318953/318953_14.png愤世嫉俗者 发表于 2025-3-24 05:22:56
http://reply.papertrans.cn/32/3190/318953/318953_15.pnguveitis 发表于 2025-3-24 09:03:26
http://reply.papertrans.cn/32/3190/318953/318953_16.pngsacrum 发表于 2025-3-24 12:28:06
http://reply.papertrans.cn/32/3190/318953/318953_17.pngperjury 发表于 2025-3-24 16:17:45
Cytokine Immunotherapyne milieu, endogenous protection may be reestablished or even enhanced. It is therefore no surprise that cytokine immunotherapy holds great theoretical promise for the treatment of cancer. This theoretical promise has been borne out in a wide variety of preclinical models but unfortunately, clinical坦白 发表于 2025-3-24 21:31:07
http://reply.papertrans.cn/32/3190/318953/318953_19.pngFillet,Filet 发表于 2025-3-25 03:10:45
Genetically Engineered Antigen Specificity in T Cells for Adoptive Immunotherapyer of modified T cells over immunotherapies developed to date such as vaccines or cytokines alone is that T cells have the ability to directly traffic to the site of tumor or infection, to multiply at that site, and to persist in a memory state for months to years.